By Ben Glickman Shares of Tarsus Pharmaceuticals rose Tuesday after the company's product sales topped Wall Street's expectations. The stock was up 13% to.
By Chris Wack Capricor Therapeutics shares were up 8%, to $4.29, after the biotechnology company said it has been granted an in-person Type-B meeting with.